International Biotechnology Trust PLC Alnylam Pharmaceuticals, Inc. Transaction History

International Biotechnology Trust PLC

$295 Million
Q3 2023

A detailed history of International Biotechnology Trust PLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, International Biotechnology Trust PLC holds 36,800 shares of ALNY stock, worth $9.01 Million. This represents 2.21% of its overall portfolio holdings.

Number of Shares

36,800

Previous 81,600 54.9%

Holding current value

$9.01 Million

Previous $15.5 Million 57.95%

% of portfolio

2.21%

Previous 4.83%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$170.77 - $211.65 $7.65 Million - $9.48 Million	-44,800 Reduced 54.9%	36,800 $6.52 Million
Q2 2023 Aug 08, 2023	BUY	$185.01 - $212.05 $6.48 Million - $7.42 Million	35,000 Added 75.11%	81,600 $15.5 Million
Q1 2023 May 18, 2023	BUY	$182.66 - $235.53 $1.57 Million - $2.03 Million	8,600 Added 22.63%	46,600 $9.33 Million
Q3 2022 Nov 08, 2022	BUY	$138.54 - $232.0 $4.5 Million - $7.53 Million	32,458 Added 585.67%	38,000 $7.6 Million
Q2 2022 Aug 16, 2022	SELL	$120.42 - $169.29 $3.91 Million - $5.49 Million	-32,458 Reduced 85.42%	5,542 $38 Million
Q1 2022 May 20, 2022	SELL	$127.18 - $173.91 $11.4 Million - $15.7 Million	-90,000 Reduced 70.31%	38,000 $6.21 Million
Q4 2021 Feb 15, 2022	BUY	$159.56 - $209.29 $8.46 Million - $11.1 Million	53,000 Added 70.67%	128,000 $21.7 Million
Q3 2021 Nov 12, 2021	SELL	$169.75 - $207.73 $12.6 Million - $15.4 Million	-74,000 Reduced 49.66%	75,000 $14.2 Million
Q2 2021 Aug 11, 2021	BUY	$128.63 - $176.89 $5.17 Million - $7.11 Million	40,200 Added 36.95%	149,000 $25.2 Million
Q1 2021 May 17, 2021	BUY	$126.83 - $175.69 $9.2 Million - $12.7 Million	72,500 Added 199.72%	108,800 $15.4 Million
Q2 2020 Jul 14, 2020	BUY	$104.21 - $156.44 $1.46 Million - $2.19 Million	14,000 Added 62.78%	36,300 $5.37 Million
Q1 2020 May 18, 2020	SELL	$93.12 - $133.99 $1.96 Million - $2.81 Million	-21,000 Reduced 48.5%	22,300 $2.43 Million
Q4 2019 May 18, 2020	BUY	$74.51 - $124.23 $707,845 - $1.18 Million	9,500 Added 28.11%	43,300 $4.99 Million
Q4 2018 Feb 14, 2019	SELL	$62.67 - $88.33 $1.19 Million - $1.68 Million	-19,000 Reduced 35.98%	33,800 $1.94 Million
Q3 2018 Nov 14, 2018	SELL	$87.52 - $122.67 $2.52 Million - $3.54 Million	-28,841 Reduced 35.33%	52,800 $3.54 Million
Q3 2018 Nov 13, 2018	BUY	$87.52 - $122.67 $3.92 Million - $5.5 Million	44,841 Added 121.85%	81,641 $8.7 Million
Q4 2017 Mar 02, 2018	SELL	$114.49 - $139.98 $515,205 - $629,910	-4,500 Reduced 10.9%	36,800 $4.68 Million
Q3 2017 Mar 02, 2018	BUY	$72.53 - $118.27 $3 Million - $4.88 Million	41,300	41,300 $4.85 Million

Others Institutions Holding ALNY

# of Institutions

642

Shares Held

109M

Call Options Held

1.28M

Put Options Held

1.21M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $30.1B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of International Biotechnology Trust PLC, based on Form 13F filings with the SEC.

News

Stay updated on International Biotechnology Trust PLC with notifications on news.

Account

International Biotechnology Trust PLC Alnylam Pharmaceuticals, Inc. Transaction History